Credit: Thinkstock. A warning about opioid-induced hyperalgesia has been added to the prescribing information. The Food and Drug Administration (FDA) has updated the prescribing information for all ...

For decades, opioids have been the blunt instrument of modern pain care, powerful enough to quiet severe suffering yet risky ...

New research reveals previously unknown ways opioid receptors can function, opening the door to safer pain treatments.

Nonopioid therapy may be superior to opioid therapy for pain control after third molar surgery among both men and women.

SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera") ...

Olinvyk is indicated for short-term intravenous use in hospitals or other controlled clinical settings. The Food and Drug Administration (FDA) has approved Olinvyk (oliceridine; Trevena) for the ...

This article evaluates the immediate and long-term efficacy of a group multidisciplinary program for chronic opioid analgesic therapy cessation in the setting of chronic, noncancer pain. Objectives: ...

PF614-301 Phase 3 Trial Enrollment Underway, Advancing Toward Market Launch FDA Aligned with ENSC Manufacturing Path for PF614, Enabling Commercial Scale Up MPAR® Patent Protection Extended Through ...

Ensysce Biosciences (ENSC) issued its 2025 annual letter to shareholders from CEO Lynn Kirkpatrick, which read in part, “2025 was a year of ...

Initiating an opioid analgesic reduced the use of antipsychotics and benzodiazepines in persons with Alzheimer's disease, a recent study shows. These drugs are frequently prescribed to treat ...

March 26 (UPI) --Opioid analgesics helped doctors reduce the use of antipsychotics and benzodiazepines to treat with Alzheimer's disease, researcher report in a new study from Finland. The two types ...